FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Dopamine Hydrochloride Injection

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-dopamine-hydrochloride-injection-hospira-inc-a-pfizer-company-0409-9104-20

Drug Shortage Details

Generic NameDopamine Hydrochloride Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryCardiovascular
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code0409-9104-20
Presentation & Dosage Form

Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.